vimarsana.com

Latest Breaking News On - Marial maccecchini - Page 6 : vimarsana.com

Annovis Bio Announces Publication of Phase 2a Clinical Data in The Journal of Prevention of Alzheimer's Disease

/PRNewswire/ Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases,.

Berwyn
Pennsylvania
United-states
Marial-maccecchini
Nic-johnson
Cheng-fang
Annovis-bio
Exchange-commission
Prnewswire-annovis-bio-inc
Company-phase
Research-development-at-annovis-bio
Drug-administration

Annovis Bio Announces FDA Authorization to Proceed with Phase 2/3 Trial for Buntanetap in Alzheimer's Disease

/PRNewswire/ Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases,.

Berwyn
Pennsylvania
United-states
Marial-maccecchini
Nic-johnson
Annovis-bio
Exchange-commission
Prnewswire-annovis-bio-inc
Annovis-bio-inc
Drug-administration
Russo-partners
Annual-report

Annovis Bio Announces Publication of Patents Covering the Treatment of Amyloid Lateral Sclerosis, Huntington's Disease and Prion Diseases

/PRNewswire/ (NYSE: ANVS) Annovis Bio ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases, announced.

Berwyn
Pennsylvania
United-states
Marial-maccecchini
Nic-johnson
Annovis-bio
Exchange-commission
Linkedin
Twitter
Annovis-bio-inc
Russo-partners
Variant-creutzfeldt-jakob

Annovis Bio's CEO Maria Maccecchini Issues Letter to Stockholders

/PRNewswire/ Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company addressing neurodegenerative diseases,.

Berwyn
Pennsylvania
United-states
Marial-maccecchini
Maria-maccecchini
Nic-johnson
Annovis-bio
Exchange-commission
Prnewswire-annovis-bio-inc
Linkedin
Twitter
Annovis-bio-inc

Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

BERWYN, Pa., Aug. 29, 2022 /PRNewswire/ Annovis Bio, Inc. , a clinical-stage drug platform company addressing neurodegenerative diseases, announced the appointment of Henry Hagopian III as Chief. | August 29, 2022

Berwyn
Pennsylvania
United-states
Marial-maccecchini
Nic-johnson
Annovis-bio
Jeff-mcgroarty
Exchange-commission
Prnewswire-annovis-bio-inc
Linkedin
Twitter
Annovis-bio-inc

vimarsana © 2020. All Rights Reserved.